Document:

EX-10.2

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 Exhibit 10.2 

LUFAX HOLDING LTD 
 (a
limited company incorporated in the Cayman Islands) 
 Incentive Stock Plan II 

(Amended and Restated) 
  

	I.	 Interpretations 

Unless otherwise stated, the following terms or abbreviations used herein shall have the following meaning: 

 

			
	 Incentive
 Stock Plan II/ this Plan
II/ Plan II
	  	means this Incentive Stock Plan II
		
	Company	  	means Lufax Holding Ltd, a company incorporated and validly existing under the laws of the Cayman Islands
		
	Board	  	means the Board of Directors of the Company
		
	Directors	  	means the Directors of the Company
		
	Administrator	  	means the Board or any director, committee or any other person designated by the Board for the purpose of administration and implementation of this Plan II
		
	Officer	  	means CEO, general manager, deputy general manager, assistant general manager, financial principal, and any other person determined in accordance with the relevant articles of association and by the Board from time to time
		
	Employee	  	means any person who maintains Employment Relationship with the Company or its Related Entity
		
	Applicable Laws	  	means requirements of any applicable laws related to the Shares, requirements of any applicable laws related to the administration of the Incentive Stock Plan, rules of any relevant stock exchange and national market mechanism, and
laws and regulations of any jurisdiction that are applicable to the grant of Option to residents residing in any jurisdiction
		
	Related Entity	  	means any entity directly or indirectly controlling the Company, controlled by the Company directly or indirectly through shares or agreement, or directly or indirectly under common control with the Company
		
	Competition Event	  	a Competition Event occurs if any Grantee (i) becomes shareholder, director, Officer, employee, adviser or partner of any competitor of the Company or Related Entity; or (2) engages in any act that may bring competitive
advantages for the competitor
		
	Disability	  	means that a Grantee is unable to carry out the responsibilities and functions of the position held by the Grantee by reason of any work-related or non-work-related Disability or disease as
evidenced by the labor ability appraisal conclusion issued by the competent agency under legal standards in accordance with laws and regulations then in force

  
 1 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

			
	Employment Relationship	  	means the labor or employment relationship with the Company and the Related Entity
		
	Exercise	  	means the act through which the Grantee purchases the issued shares of the Company at the previously determined price upon the previously determined terms and conditions within the specified period
		
	Exercise Price	  	means the price at which the Grantee purchases shares, which is determined by the Board at time of granting the option to the Grantee and specified in the grant notification of option
		
	Fair Market Value of Shares	  	means, as of any date, the value of Shares determined as follows: (i) if the Shares are traded in an open market, fair market value shall be the closing price per share as quoted on the principal exchange the Board determines
to be the principal market on the last trading date immediately prior to the date of determination (or if no closing price is reported on that date, the closing price on the last trading date on which such closing price is reported) or (ii) in
the absence of an open market for trading of Shares described in (i) above, the fair market value shall be determined by the Board in good faith on the basis of the following factor: value per share appraised by a qualified appraiser approved
by the Board
		
	Grant	  	means the act of giving the Option to the Grantee under this Plan II
		
	Grant Date	  	means the date on which the Option is granted to the Grantee
		
	Initial Date of Exercise	  	means the date on which the Grantee is entitled to exercise
		
	Initial Public Offering	  	means initial public offering and listing of the Company on a Qualified Stock Exchange
		
	Grantee	  	means Employees and any other person determined by the Board who are eligible to participate in this Plan II hereunder
		
	Qualified Stock Exchange	  	Means the Stock Exchange of the Hong Kong Limited, the New York Stock Exchange, the NASDAQ Stock Exchange and other internationally recognized stock exchanges
		
	Stock	  	means (i) the ordinary A shares of the Company prior to the Initial Public Offering; or (ii) ordinary shares of the Company with a par value of US$0.00001 per share after the Initial Public
Offering

  
 2 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

			
	Shareholder of the Company	  	means existing shareholder of the Company, excluding future contingent investor of the Company or any Grantee appearing after exercising of any Incentive Stock Plan (including this Plan II)
		
	Stock Option/ Option	  	means the right granted to a Grantee to purchase a certain number of issued shares of the Company over a certain period at the previously agreed price on the agreed terms and conditions
		
	Grant Notification of Option	  	means the notice given to eligible Grantees to grant a certain number of options to such Grantees
		
	Vesting	  	means an act of administration through which a certain number of options that are non-exercisable become exercisable within the agreed timeframe in consideration of the company’s
performance and the achievement of Grantees
		
	Validity Period	  	means the time slot commencing from the date on which the Option is granted to the Grantee and expires on the date on which the Option becomes invalid

  

	II.	 General Provisions 

 

	 	1.	 To attract and retain talents, promote long-term sustainable development of the Company and its Related
Entities, maximize the value of shareholders and achieve win-win situation among shareholders, the Company and employees, the Board formulates and entrusts the Administrator to implement this Plan II.

  

	 	2.	 Eligible Grantees will be granted a certain number of Options which will be vested and exercised, when they
meet certain conditions and time requirements, and ultimately obtain the corresponding Shares. 

  

	III.	 Grant of Option 

 

	 	1.	 This Plan II shall only apply to the Options granted prior to the Initial Public Offering. If Options are
needed to be granted after the Initial Public Offering, the Company shall formulate a new Incentive Stock Plan in accordance with the requirements of the jurisdiction where the listing takes place and Grant accordingly. Meanwhile, the Options
granted prior to the Initial Public Offering will not be affected, and are still subject to the rules outlined in this Plan II. 

  

	 	2.	 The maximum aggregate number of shares to be used hereunder is 10,000,000 shares. 

 

	 	3.	 The Board inspects and decides whether to grant Options on an annual basis based on the need of business
development. 

  
 3 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	4.	 The scope of the granting group, grantees, and granting amount of each installment of option granting plans are
determined by the Board based on the positions and performance of the Grantees. 

  

	 	5.	 The Exercise Price of options granted in each installment shall be arranged to valuate by the Board and
determined according to the following principles, and shall be specified in the Grant Notification of Option then issued to the Grantees: 

  

	 	(1)	 The Exercise Price of option shall not be lower than the higher of the following: 

 

	 	(a)	 the Fair Market Value of Shares on the Grant Date; 

 

	 	(b)	 the par value of the share. 

 

	 	(2)	 Subject to the listing rules and laws, the Board is entitled to ultimately decide on the Exercise Price of the
Option. 

  

	 	6.	 Unless otherwise provided by Applicable Laws and agreed by the Board, the Grantee shall not pledge, transfer or
dispose of the Options in any other way during the Validity Period; and on and after the date on which the Options are disposed of in violation of the Plan II, all the Options held by the Grantee (regardless of whether effective or not) shall be
forfeited. Without affecting the forgoing, this Plan II shall be binding on the successor or assignee of the Grantee. 

  

	 	7.	 The Granting, Vesting, Exercise and all other steps of Options shall comply with this Plan II, relevant
resolutions adopted by the Board and provisions of Applicable Laws. The Company, Shareholders of the Company and Related Entities shall not be responsible for failure to obtain the necessary approval, registration or filing for Grant, Vesting,
exercise and other matters of Options from any competent regulator not due to intentional or gross negligence on the part of the Company, Shareholders of the Company or Related Entities. 

 

	 	8.	 The Board shall formulate the Key Terms of the Incentive Stock Plan II and the Notice Letter to Employees (the
“Notice Letter”), and the Grantee shall sign and promise to abide by the Notice Letter before obtaining the eligibility for Option. 

  

	IV.	 Vesting of option 

 

	 	1.	 Unless otherwise decided by the Board, in principle, the options granted in each installment shall be vested
for 4 years, and the maximum amount of options that are vestable in each year shall be 25% of the total options granted in such installment. The first vesting date shall be the first anniversary date of the Grant Date (or the next day if there is no
anniversary date). 

  
 4 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	2.	 The Board shall, according to the base of options to be vested in per year (that is, the total options granted
in the installment/predicted times of vesting), calculate the number of options actually vested based on the performance of the Company and individuals: 

  

	 	(1)	 The Board shall determine the option vesting coefficient for each year according to the overall operating
objective and achievement of the Company. The number of options actually vested by a Grantee in the year shall be the product of the current option vesting base of such Grantee and the said coefficient (the “Actual Effective Amount of that
Year”). For the first three vestings, if the option vesting coefficient for a year is less than 100%, the unvested portion may be postponed to the vesting time point of the next year (which may only be postponed to the next year of the
current year, but not to the third year) to judge whether such option is vestable: if 1) the option vesting coefficient for the next year is 100%, then all the unvested options is entitled to be vested; 2) option vesting coefficient for the next
year is less than 100%, all the unvested options shall be canceled. For the fourth vesting, if the option vesting coefficient for that year is less than 100%, the unvested portion shall be immediately canceled. 

 

	 	(2)	 If the last personal annual performance ranking of a Grantee falls within the last 10% of his/her ranking
group, such Grantee shall be disqualified for vesting the option for the current year, and the corresponding options that are vestable for that year shall be canceled, for which the Company will not make any other compensation.

  

	 	3.	 Notwithstanding the foregoing, The Board may, in accordance with its authority: 

 

	 	(1)	 stipulate separately the number of times and amount of each installment of options to be vested, either as a
whole or individually; and 

  

	 	(2)	 stipulate separately the special disposal of Options, either as a whole or individually. 

 

	V.	 Exercise of Option 

 

	 	1.	 Except as otherwise provided in this Plan II, the Validity Period of each installment of Option granted to the
Grantee shall be 10 years from the Grant Date, and the Options that are not exercised during the Validity Period shall be canceled. If the Company is not listed at the expiration of the Validity Period, the Board may decide whether to extend the
Validity Period if necessary. 

  
 5 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	2.	 Except as otherwise provided by this Plan II and the Board or required by Applicable Laws, the Grantee shall,
at its sole discretion, exercise the vested options from the Initial Date of Exercise to the end of Validity Period. The Initial Date of Exercise shall be no earlier than 180 days before the date of Initial Public Offering or 6 months after the date
of Initial Public Offering; and the maximum interval between the Initial Date of Exercise and the Grant Date shall not exceed 8 years. The Grantee will be notified in due course of the specific Initial Date of Exercise by the Board.

  

	 	3.	 The Grantee shall exercise the option at Exercise Price determined at the time of grant and stated in the Grant
Notification of Option, and shall bear corresponding taxes, foreign exchange and other costs. If, for any reason attributable to the Grantee, including but not limited to insufficient personal funds and issues concerning personal foreign exchange,
the Grantee fail to exercise the Options in full, Grantee shall bear the consequential responsibilities and losses. 

  

	 	4.	 When exercising the Option, the Grantee shall pay taxes in full in accordance with the provisions of the
relevant laws and regulations. If the Company or Related Entities is then required to withhold the tax, the Grantee shall cooperate with the Company or Related Entities. 

 

	 	5.	 The option may only be exercised by the Grantee and the successor determined according to this Plan II. A
option shall have been exercised if the Grantee issues exercise notice to the Company and/or other entities determined by the Board according to the relevant provisions of this Plan II (the Company shall properly determine and provide the form of
exercise notice), fully pays the Exercise Price and taxes according to the laws, and if the registered holders of the relevant issued shares of the Company are changed to the Grantee. 

 

	 	6.	 Before a Grantee is registered as the stockholder in the register of shareholders of the Company, such Grantee
shall not be entitled to any shareholders’ rights or interests attached to any share underlying the Option under this Plan II. 

  

	 	7.	 After a Grantee becomes a stockholder of the Company by exercise of his/her option under this Plan II, such
Grantee shall be bound by the articles of association and other relevant documents of the Company. For the avoidance of doubt, except as otherwise provided in this Plan II, the Grantee shall not be entitled to any rights superior to other
shareholders, including but not limited to drag-along right, preemption right, tag-along right or right of first refusal. 

 

	 	8.	 To the extent permitted by the Applicable Laws and in case of viability, notwithstanding the paragraph 5 of
this section, as an alternative to the payment and exercise method of Exercise Price listed in this Plan II, with the consent of the Board, the Grantee may pay the Exercise Price by “simultaneous sale” promise. In other words, the Grantee
irrevocably chooses to exercise his/her option, and at the same time he/she sells the stocks purchased due to exercise that can at least pay the Exercise Price (up to all the stocks purchased due to exercise), and the Grantee promises to directly
pay the equal consideration of the Exercise Price to the Company when selling the stocks, and the sales proceeds exceeding the Exercise Price shall be paid to the Grantee. 

  
 6 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	9.	 Unless approved by the Board, any transfer of shares under the option by the Guarantee shall be publicly
conducted on the secondary market, and any such share shall not be transferred by other means (including but not limited to the transfer inside the Grantee). The transfer of such shares by the Grantee shall also comply with the laws and regulations
of the place where the shares are listed and the rules of the exchange (including but not limited to the provisions on the lock-up period). 

 

	 	10.	 The exercise of the option and the issuance and transfer of the share under the option shall comply with all
the Applicable Laws, and shall obtain the approval from the Company’s counsel about the legitimacy, otherwise shares exercisable shall not be issued. 

  

	 	11.	 The Board may, in accordance with its authority, stipulate separately the maximum number of options that is
entitled to be exercised in each year after the Initial Date of Exercise, either as a whole or individually. 

  

	VI.	 Special Disposal of Option 

 

	 	1.	 If a Grantee cancels or terminates the employment relationship with the company he/she works for:

  

	 	(1)	 if the employment with the Company is terminated or expires (except for the circumstances described in items
(2) and (3) of paragraph 1 of this section) for whatever reason, all the Options held by such Grantee (whether effective or not) shall be forfeited, and the Company shall not make any compensation; 

 

	 	(2)	 if a Grantee retires after he/she serves for more than 5 years in the Company and reaches the legal retirement
age, or if a Grantee early retires, leaves office and dies due to Disability resulted from work-related injury, the granted Option may be further held, vested or exercised by such Grantee or his/her successor; 

 

	 	(3)	 if a Grantee early retires, leaves office and dies not due to Disability resulted from work-related injury,
such Grantee or his/her successor may continue holding and exercising all vested Options; and the outstanding Options shall be forfeited, for which the Company shall not make any compensation. 

 

	 	2.	 In case of any violation of discipline and regulations committed by any Grantee during his/her employment, the
Company or any other entity determined by the Board shall have the right to properly dispose of the Options held by such Grantee according to the actual situation, including but not limited to: 

  
 7 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	(1)	 if the options of such Grantee have not been exercised, the Company or any other entity determined by the Board
shall have the right to cancel all or part of the options (whether effective or not) without any compensation. 

  

	 	(2)	 if the options of such Grantee have been exercised, the Company or any other entity determined by the Board
shall have the right to repurchase all or part of the shares acquired by such Grantee due to the exercise once or several times at any time at the lower of the Exercise Price paid by such Grantee (if applicable) or the Fair Market Value of Shares
(approved by the Board), and the times and amount of repurchase of the shares shall be determined by the Company or any other entity determined by the Board. 

 

	VII.	 Competition Event 

 

	 	1.	 In case of any Competition Event of any Grantee: 

 

	 	(1)	 If, during the existence of the employment relationship or within 3 years after the cancellation or termination
of the employment relationship, any Grantee engages in any Competition Event without the written consent of the company he/she works for or the Company, all the Options (whether effective or not) held by the Grantee shall be forfeited without any
compensation; 

  

	 	(2)	 After a Grantee exercises his/her option, the Company or any other entity determined by the Board shall have
the right (but not the obligation) to repurchase the shares obtained by the Grantee due to such exercise upon the following terms: after such Grantee engages in a Competition Event, the Company or any other entity determined by the Board shall have
the right to repurchase all or part of the shares acquired by such Grantee due to the exercise or vesting of such Option once or several times at any time at the lower of the Exercise Price paid by such Grantee (if applicable) or the fair market
value of the shares (approved by the Board), and the times and amount of repurchase of the shares shall be determined by the Company or any other entity determined by the Board. 

 

	VIII.	 Related Matters 

 

	 	1.	 If any Shareholder of the Company proposes to transfer 80% or more of issued ordinary shares of the Company to
a third party prior to the Initial Public Offering , and such shareholder requires any Grantee to transfer its shares in the Company (if any) to the third-party purchaser, the Grantee must transfer its shares in the Company to such purchaser at the
same price. 

  

	 	2.	 This Plan II and information and documents relating to any stock incentive shall be confidential information.
Any Grantee shall not disclose it to any third party without the prior written consent of the Board. 

  
 8 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	3.	 The Board is entitled to interpret this Plan II. Any determination and interpretation made by the Board shall
be final, conclusive and binding on all parties. 

  

	IX.	 Administration Body of this Plan II and its Duties 

 

	 	1.	 The Board is responsible for determining the principles and framework of the Plan II and ultimately reviewing
and approving the relevant matters of the Plan II. 

  

	 	2.	 The Board may, depending on the circumstances, authorize the Administrator to carry out relevant matters and
some functions and powers related to the implementation of this Plan II. 

  

	 	3.	 This Plan II, after being approved, shall be administered and implemented by the Board or the Administrator.

  

	 	4.	 During the term of this Plan II, the Company shall retain a certain amount of its authorized share capital.
Such amount of capital stock shall be sufficient to satisfy the requirements of this Plan II. 

  

	 	5.	 In the event of an increase or decrease in the number of shares issued by the Company due to stock split,
dividends, merger, reclassification or similar transactions affecting shares, the Board shall have the right to adjust the Options under this Plan II, the number and price of shares and other matters, and the Board’s decision shall be final and
binding. If the Company issues any type of share or securities that can be converted into any type of share, the shares obtained by the Grantee due to exercise of relevant Options will be diluted accordingly, that is, the proportion of such shares
in all issued shares of the Company will be reduced accordingly. 

  

	X.	 In the event that the Applicable Laws change or adjust, the Board may designate another entity’s
options to replace the options originally granted. The specific plan shall be decided by the Board and the Grantee shall accept it unconditionally. 

  

	XI.	 The Board has the right to terminate, revise or adjust this Plan II in any event, the Board shall
determine corresponding compensation plan, and the Grantee shall accept it unconditionally. 

  

	XII.	 The Board reserves the right to amend this Plan II in accordance with Applicable Laws or as required for
the development of the Company, and the Grantee shall accept relevant future amendments. 

  
 9 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	XIII.	 Entire Agreement 

This Plan II, the Grant Notification of Option and the Notice Letter shall jointly constitute the entire agreement of the Grantees and the
Company with respect to this Plan II and supersede all prior undertakings and agreements between the Company and the Grantees with respect to this Plan II in their entirety. Nothing in this Plan II, the Grant Notification of Option and the Notice
Letter (unless expressly provided in such documents) shall be deemed to be intended to grant to any person other than the Grantees and the Company any rights or remedies. 
  

	XIV.	 Governing Law 

This Plan II, the Grant Notification of Option and the Notice Letter shall be governed by and construed in accordance with PRC laws (excluding
Hong Kong Special Administrative Region, Macao Special Administrative Region and Taiwan). If any provision of this this Plan II, the Grant Notification of Option and the Notice Letter is found to be invalid or unenforceable, then such provision
shall be enforced to the fullest extent permitted by law, and the other provisions shall be valid and enforceable. 
  

	XV.	 Dispute Resolution 

Any dispute arising from this Plan II, the Grant Notification of Option and the Notice Letter or in relation to them shall be submitted to
Shanghai International Economic and Trade Arbitration Commission for arbitration which shall be conducted in accordance with the arbitration rules in effect at the time of applying for arbitration. The arbitral award shall be final and binding upon
the Parties. The arbitration place shall be Shanghai. 
  

	XVI.	 Title 

The titles used in this Plan II, the Grant Notification of Option and the Notice Letter shall be for convenience only and shall not be deemed
to be part of the Document or affect the interpretation thereof. 
  

	XVII.	  Notice 

Any notice required or permitted under this document shall be given electronically or in writing. If in writing, the notice shall be deemed
effectively given upon delivery to the address shown on the records of the Company or as updated from time to time. 

  
 10EX-10.3

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 Exhibit 10.3 

LUFAX HOLDING LTD 
 (a
limited company incorporated in the Cayman Islands) 
 Performance Stock Unit Plan 

 

	I.	 Interpretations 

Unless otherwise stated, the following terms or abbreviations used herein shall have the following meaning: 

 

			
	Company	  	means Lufax Holding Ltd, a company incorporated under the laws of the Cayman Islands
		
	Board	  	means the Board of Directors of the Company
		
	Directors	  	means the Directors of the Company
		
	Administrator	  	means the Board or any director, committee or any other person designated by the Board for the purpose of administration and implementation of this Plan
		
	Officer	  	means CEO, general manager, deputy general manager, assistant general manager, financial principal and any other person determined in accordance with the relevant articles of association and by the Board from time to time
		
	Employee	  	means any person who maintains Employment Relationship with the Company or its Related Entity
		
	Applicable Laws	  	means requirements of any applicable laws related to the Shares, requirements of any applicable laws related to the administration of the PSU Plan, rules of any relevant stock exchange and national market mechanism, and laws and
regulations of any jurisdiction that are applicable to the grant of PSU to residents residing in any jurisdiction
		
	Related Entity	  	means any entity directly or indirectly controlling the Company, controlled by the Company directly or indirectly through shares or agreements, or directly or indirectly under common control with the Company
		
	Competition Event	  	a Competition Event occurs if any Grantee (i) becomes shareholder, director, Officer, employee, adviser or partner of any competitor of the Company or Related Entity; or (2) engages in any act that may bring competitive
advantages for the competitor
		
	Disability	  	means that a Grantee is unable to carry out the responsibilities and functions of the position held by the Grantee by reason of any work-related or non-work-related Disability or disease as
evidenced by the labor ability appraisal conclusion issued by the competent agency under legal standards, in accordance with laws and regulations then in force

  
 1 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

			
	Employment Relationship	  	means the labor or employment relationship with the Company and the Related Entity
		
	Fair Market Value of Shares	  	means, as of any date, the value of Shares determined as follows: (i) if the Shares are traded in an open market, fair market value shall be the closing price per share as quoted on the principal exchange the Board determines
to be the principal market on the last trading date immediately prior to the date of determination (or if no closing price is reported on that date, the closing price on the last trading date on which such closing price is reported) or (ii) in
the absence of an open market for trading of Shares described in (i) above, the fair market value shall be determined by the Board in good faith on the basis of the following factor: value per share appraised by a qualified appraiser approved
by the Board or the Administrator
		
	Grant	  	means the act of giving the PSU to the Grantee under this Plan
		
	Grant Date	  	means the date on which the PSU is granted to the Grantee
		
	Grant Notification	  	means the notice given to eligible Grantees to grant a certain number of PSU to such Grantees
		
	Initial Date of Settlement	  	means the date on which the Grantee is entitled to do the Settlement
		
	Initial Public Offering	  	means initial public offering and listing of the Company on a Qualified Stock Exchange
		
	Listing Rules	  	means Hong Kong Listing Rules or listing rules of the Qualified Stock Exchange designated by the Board
		
	Hong Kong Listing Rules	  	means Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited
		
	Grantee	  	means Directors, Officers, Employees, consultants and any other person determined by the Board who are eligible to participate in this Plan
		
	Performance Stock Unit/ PSU	  	means the Performance Stock Unit granted to a Grantee
		
	Performance Stock Unit Plan/ this Plan/ Plan	  	means this Performance Stock Unit Plan
		
	Qualified Stock Exchange	  	Means the Stock Exchange of the Hong Kong Limited, the New York Stock Exchange, the NASDAQ Stock Exchange and other internationally recognized stock exchanges

  
 2 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

			
	Share	  	means (i) the ordinary A shares of the Company prior to the Initial Public Offering; or (ii) the ordinary shares of the Company with a par value of US$0.00001 per share after the Initial Public Offering
		
	Shareholder of the Company	  	means existing shareholder of the Company, excluding any grantee appearing after exercising or settlement of any stock incentive plan (including this Plan)
		
	Vesting	  	means an act of administration through which a certain number of PSUs that are non-settlable become settlable within the agreed timeframe in consideration of the Company’s performance, the growth of the stock price and the
achievements of Grantees
		
	Validity Period	  	means the time slot commencing from the date on which the PSU is granted to the Grantee and expires on the date on which the PSU becomes invalid
		
	Settlement	  	means the settlement of the PSUs within the specified time limit in accordance with the circumstances stipulated in this Plan. The stock underlying the PSUs shall be registered in the name of the Grantees subject to Applicable Laws
after settlement
		
	Shareholding Entity	  	means the entity designated by the Board to hold the PSUs under this Plan

  

	II.	 General Provisions 

 

	 	1.	 To attract and retain talents, promote long-term sustainable development of the Company and its Related
Entities, maximize the value of shareholders and achieve win-win situation among shareholders, the Company and employees, the Board formulates and entrusts the Administrator to implement this Plan.

  

	 	2.	 Eligible Grantees will be granted a certain number of PSUs, when they meet certain conditions and certain time
point requirements, the PSUs granted to the Grantees will then be Vested, Settled, and the Grantees will ultimately obtain and sell the corresponding stock and receive the proceeds from sale of them. 

 

	III.	 Grant of PSU 

  

	 	1.	 The maximum aggregate number of Shares to be used hereunder is 15,000,000. 

 

	 	2.	 The Board inspects and decides whether to grant PSUs on an annual basis based on the need of business
development. 

  
 3 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	3.	 The scope of the granting group, Grantees, and granting amount of each installment of PSU granting plans are
determined by the Board or the Administrator based on the positions and performance of the Grantees. 

  

	 	4.	 Unless otherwise provided by Applicable Laws and agreed by the Board, the Grantee shall not pledge, transfer or
dispose of the PSUs in any other way during the Validity Period; and on and after the date on which the PSUs are disposed of in violation of the Plan, all the PSUs held by the Grantee which have not been Settled (whether Vested or not) shall be
invalid or forfeited. Without affecting the forgoing, this Plan shall be binding on the successor or assignee of the Grantee. 

  

	 	5.	 The Grant, Vesting, Settlement and all other steps of PSUs shall comply with this Plan, relevant resolutions
adopted by the Board and provisions of Applicable Laws. The Company, Shareholders of the Company and Related Entities shall not be responsible for failure to obtain the necessary approval, registration or filing for Granting, Vesting, Settlement and
other steps of PSUs from any competent regulator not due to intentional or gross negligence on the part of the Company, Shareholders of the Company or Related Entities. 

 

	 	6.	 The Board shall formulate the Key Terms of the Performance Stock Unit Plan and the Notice Letter to Employees
(the “Notice Letter”), and the Grantee shall sign and promise to abide by the Notice Letter before obtaining the eligibility for PSUs. 

  

	 	7.	 If the Grantees are or are likely to be restricted or prohibited from trading securities according to the
Listing Rules (if applicable) or any other applicable rules, regulations or laws, the Company shall not grant to the Grantee, and even the Company grants, the Grantee shall not accept it. 

[Note: The following items (8) to (11) apply only if the Company is listed in Hong Kong.] 

 

	 	8.	 [After the Company completes its Initial Public Offering in Hong Kong, it shall not grant the PSUs after
becoming aware of insider information until the relevant insider information has been published in accordance with the Hong Kong Listing Rules. In particular, no PSUs nor any other equity-related incentives shall be granted during the period from
one month immediately before the following date (whichever is the earlier) to the performance publication date: 

  

	 	(1)	 The date on which the Board meeting is held for the purpose of passing the Company’s annual, semi-annual,
quarterly or any other interim period performance by the Board (whether or not in accordance with Hong Kong Listing Rules) (that is, the date when the Stock Exchange of Hong Kong Limited is first notified according to Hong Kong Listing Rules); and

  
 4 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	(2)	 The deadline or performance publication date on which the Company publishes its annual or semi-annual,
quarterly or any other interim performance (whether or not in accordance with Hong Kong Listing Rules) (whichever is the later) in accordance with Hong Kong Listing Rules. 

 

	 	9.	 After the completion of Initial Public Offering in Hong Kong, no incentives shall be granted to any Director of
the Company in connection with any PSUs or other equity-related incentives on the date of the publication of the Company’s financial performance or during the period set out below: 

 

	 	(1)	 Immediately 60 days prior to the annual performance publication date or the period from the end of the relevant
financial year to the performance publication date (whichever is shorter); and 

  

	 	(2)	 Immediately 30 days prior to the quarterly performance (if any) and semi-annual performance publication date,
or the period from the end of the quarterly or semi-annual period to the release date of the performance (whichever is shorter). 

  

	 	10.	 Upon completion of the Initial Public Offering in Hong Kong, the grant to any Director, chief executive officer
or major shareholder of the Company or any of their respective Contacts (as defined in Hong Kong Listing Rules) shall obtain the prior approval of the independent non-executive directors (excluding those who
are independent non-executive directors serving as proposed incentive successors), and will otherwise be subject to compliance with Hong Kong Listing Rules. Notwithstanding the foregoing, where incentives
granted to Directors of the Company form part of the remuneration of the relevant Directors pursuant to his/her service contract, in accordance with Section 14A.95 of Hong Kong Listing Rules, incentives granted to Directors will be exempt from
the filing, announcement and independent shareholder approval requirements. 

  

	 	11.	 The Board shall not grant any incentive to any participant under any of the following circumstances:

  

	 	(1)	 the requisite approval of any applicable regulatory authority has not been obtained in respect of such grant;
or 

  

	 	(2)	 the prospectus or other offering documents relating to the grant or the Plan is required by securities laws,
unless otherwise determined by the Board; or 

  

	 	(3)	 the grant would result in violation of applicable securities laws, rules or regulations by any member of the
Group or any Director of such member; or 

  

	 	(4)	 the grant would result in a breach of the PSU Limit or other rules of this Plan.] 

  
 5 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	IV.	 Vesting of PSU 

 

	 	1.	 Unless otherwise decided by the Board, in principle, the PSUs granted in each installment shall be vested for 4
years, the first date of Vesting shall be the first anniversary date of the Grant Date (or the next day if there is no anniversary date) and the maximum amount of PSUs that are qualified to vest in each year shall be 25% of the total PSUs granted in
such installment. 

  

	 	2.	 The Board shall, according to the base of PSUs to be vested in per year (that is, the total PSUs granted in the
installment/predicted times of vesting), calculate the number of PSUs actually vested based on the performance of the Company and individuals: 

  

	 	(1)	 The Board shall annually determine (i) the Company’s stock price coefficient (the “Stock
Price Coefficient”) and (ii) the current year’s performance coefficients of the Company and each Related Entity (the “Performance Coefficient”, together with the “Stock Price Coefficient” are
collectively referred to as the “PSU Effective Coefficient”) in accordance with the methods set out in Schedule A. The current PSU vesting base multiplied by the PSU Effective Coefficient shall be the actual vesting amount of the
Grantee of that year (the “Actual Vesting Amount of that Year”). 

  

	 	(2)	 If the last personal annual performance ranking of a Grantee falls within the last 10% of his/her ranking
group, such Grantee shall be disqualified for vesting the PSU for that year, and the corresponding PSUs that are vestable for that year shall be canceled, for which the Company shall not make any other compensation. 

 

	 	3.	 Notwithstanding the foregoing, the Board may, in accordance with its authority: 

 

	 	(1)	 stipulate separately the number of times and amount of each installment of PSUs to be vested, either as a whole
or individually; and 

  

	 	(2)	 stipulate separately the rules of special disposal of PSUs, either as a whole or individually.

  

	V.	 Settlement of PSU 

 

	 	1.	 Except as otherwise provided in this Plan, the Validity Period of each installment of PSUs granted to the
Grantee shall be 10 years from the Grant Date, and the PSUs that are not Settled during the Validity Period shall be canceled. If the Company is not listed at the expiration of the Validity Period, the Board may decide whether to extend the Validity
Period if necessary. 

  

	 	2.	 Except as otherwise provided by this Plan and the Board or required by Applicable Laws, the Initial Date of
Settlement shall be no earlier than 180 days before the date of Initial Public Offering, or 6 months after the date of Initial Public Offering; and the maximum interval between the Initial Date of Settlement and the Grant Date shall not exceed 8
years. The Grantee will be notified in due course of the specific Initial Date of Settlement by the Board. 

  
 6 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	3.	 Except as otherwise provided by this Plan, (i) PSUs that are vested prior to the Initial Public Offering
shall do the Settlement immediately at the earliest Initial Date of Settlement as provided in paragraph 2 of this section; (ii) PSUs that are vested after the Initial Public Offering shall do the Settlement immediately upon Vesting.

  

	 	4.	 If the Initial Public Offering plan of the Company is delayed or cancelled due to external policy environment
or adjustment of the Company’s strategy, the Board shall have the right to make necessary adjustments to the PSU Plan. 

  

	 	5.	 After the Settlement of the PSUs held by the Grantees, with respect to the shares underlying such settled PSUs,
the Board or other entity, committee or other person designated by the Board may (i) require the Shareholding Entity to transfer a certain number of issued shares held by him/her in proxy to the Grantee in accordance with the Plan and register
the holder of such issued Shares in the name of the Grantee; or (ii) approve the issuance of stock by the Company and register the holders of newly issued stock in the name of the Grantee. Upon satisfaction of the regulatory requirements of
Qualified Stock Exchange and other securities regulatory authorities for the shareholding period, the Grantees may then sell the stocks and receive the proceeds from sale of the stocks. 

 

	 	6.	 The Grantee shall pay the price payable as determined at the time of Grant and as set out in the Grant
Notification of PSU, and shall bear corresponding taxes, foreign exchange costs and other costs. If, for any reason attributable to the Grantee, including but not limited to insufficient personal funds and issues concerning personal foreign
exchange, the Grantee fail to pay the price payable in full, Grantee shall bear the consequential responsibilities and losses. The price payable under the item(ii) of paragraph 5 in this section of the Plan shall be no lower than the par value of
the newly issued shares. 

  

	 	7.	 When doing the Settlement of the PSUs, the Grantee shall pay taxes in full in accordance with the provisions of
the relevant laws and regulations. If the Company or Related Entity is then required to withhold the tax, the Grantee shall cooperate with the Company or Related Entity. 

 

	 	8.	 The PSUs shall only be held by the Grantee and the successor determined according to this Plan.

  
 7 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	9.	 Before a Grantee is registered as the stockholder in the register of shareholders of the Company, such Grantee
shall not be entitled to any shareholders’ rights or interests attached to any share underlying the PSUs under this Plan. 

  

	 	10.	 After a Grantee becomes a stockholder of the Company by doing the Settlement of his/her PSUs under this Plan,
such Grantee shall be bound by the articles of association and other relevant documents of the Company. For the avoidance of doubt, except as otherwise provided in this Plan, the Grantee shall not be entitled to any rights superior to other
shareholders, including but not limited to drag-along right, preemption right, tag-along right or right of first refusal. 

 

	 	11.	 To the extent permitted by the Applicable Laws and in case of viability, notwithstanding the paragraph 6 of
this section, as an alternative to the payment of price payable as set out in this Plan, with the consent of the Board, the Grantee may pay the price payable by “simultaneous sale” promise. In other words, the Grantee irrevocably elects to
sell the stocks underlying his/her PSUs at least that number of Shares so purchased to pay the price payable (up to all the stocks due to Settlement), and the Grantee commits upon sale of such Shares to forward the price payable directly to the
Company with the sales proceeds (if applicable, and shall less the corresponding taxes and foreign exchange and other costs) in excess of the price payable being for the benefit of the Grantee. 

 

	 	12.	 Unless agreed by the Board or the stocks underlying the PSUs are continued to be held by the successors in case
of the death of a Grantee, any transfer of shares underlying the Settled PSUs with the Grantees registered as stockholder shall be publicly conducted on the secondary market, and any such share shall not be transferred by other means (including but
not limited to the transfer inside the Grantee). The transfer of such shares by the Grantee shall also comply with the regulatory requirements of Qualified Stock Exchange and other securities regulatory authorities and Applicable Laws (including but
not limited to the provisions on the lock-up period). 

  

	 	13.	 The Settlement of the PSUs and the issuance and transfer of the share underlying the PSUs shall comply with all
the Applicable Laws, otherwise shares Settled shall not be issued and transferred. 

  

	 	14.	 The Board may, in accordance with its authority, stipulate separately the maximum number of PSUs that can be
Settled in each year after the Initial Date of Settlement, either as a whole or individually. 

  

	VI.	 Special Disposal of PSU 

 

	 	1.	 If a Grantee cancels or terminates the employment relationship with the company he/she works for:

  
 8 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	(1)	 for whatever reason (i) if the employment is terminated or expires (except for the circumstances described
in items (2) and (3) of paragraph 1 of this section) prior to the Initial Public Offering, all the PSUs held by such Grantee (whether vested or not) shall be forfeited, for which the Company shall not make any compensation; (ii) the
employment is terminated or expires (except for the circumstances described in items (2) and (3) of paragraph 1 of this section) after the Initial Public Offering (except for the circumstances under items (2) and (3) of paragraph 1 of this
section), without prejudice to all Settled PSUs held by the Grantees, all unsettled PSUs (whether vested or not) shall be forfeited, for which the Company shall not make any compensation. 

 

	 	(2)	 if a Grantee retires after he/she serves for more than 5 years in the Company and reaches the legal retirement
age, or if a Grantee early retires, leaves office and dies due to Disability resulted from work-related injury, the granted PSUs(whether vested or not) may be further held by such Grantee or his/her successor, and be vested, Settled and sold for the
proceeds in accordance with this Plan. 

  

	 	(3)	 if a Grantee early retires, leaves office and dies not due to Disability resulted from work-related injury,
such Grantee or his/her successor may continue holding all vested PSUs; and the outstanding PSUs shall be forfeited, for which the Company shall not make any compensation. 

 

	 	2.	 In case of any violation of discipline and regulations committed by any Grantee during his/her employment, the
Company or any other entity determined by the Board shall have the right to properly dispose of the PSUs held by such Grantee according to the actual situation, including but not limited to: 

 

	 	(1)	 if the PSUs of such Grantee have not been Settled, the Company or other entity, committee or any other person
determined by the Board shall have the right to cancel all or part of the PSUs (whether vested or not) without any compensation; 

  

	 	(2)	 if the PSUs of such Grantee have been Settled, the Company or any other entity determined by the Board shall
have the right to repurchase all or part of the shares acquired by such Grantee due to the Settlement of PSUs once or several times at any time at the Fair Market Value of Shares (approved by the Board), and the times and amount of repurchase of the
shares shall be determined by the Company or any other entity determined by the Board at its sole discretion. 

  

	VII.	 Competition Event 

 

	 	1.	 In case of any Competition Event of any Grantee: 

 

	 	(1)	 If, during the existence of the employment relationship or within 3 years after the cancellation or termination
of the employment relationship, any Grantee engages in any Competition Event without the written consent of the company he/she works for or the Company, all the PSUs (whether vested or not) held by the Grantee shall be forfeited without any
compensation; 

  
 9 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	 	(2)	 All Settled PSUs held by the Grantees will not be affected thereby. 

 

	VIII.	 Related Matters 

 

	 	1.	 If any Shareholder of the Company proposes to transfer 80% or more of issued ordinary shares of the Company to
a third party prior to the Initial Public Offering , and such shareholder requires any Grantee to transfer its shares in the Company (if any) to the third-party purchaser, the Grantee must transfer its shares in the Company to such purchaser at the
same price. 

  

	 	2.	 This Plan and information and documents relating to PSU shall be confidential information. Any Grantee shall
not disclose it to any third party other than his/her attorneys, tax advisors and other professional advisors without the prior written consent of the Board. 

  

	 	3.	 The Board is entitled to interpret this Plan. Any determination and interpretation made by the Board shall be
final, conclusive and binding on all parties. 

  

	IX.	 Administration Body of this Plan and its Duties 

 

	 	1.	 The Board is responsible for determining the principles and framework of the Plan and ultimately reviewing and
approving the relevant matters of the Plan. 

  

	 	2.	 The Board may, depending on the circumstances, authorize the Administrator or any committee authorized by the
Board for this purpose to carry out relevant matters and some functions and powers related to the implementation of this Plan. 

  

	 	3.	 This Plan, after being approved, shall be administered and implemented by the Board or the Administrator or any
committee authorized by the Board for this purpose. 

  

	 	4.	 During the term of this Plan, the Company shall retain a certain amount of its authorized share capital. Such
amount of capital stock shall be sufficient to satisfy the requirements of this Plan. 

  

	 	5.	 In the event of an increase or decrease in the number of shares issued by the Company due to stock split,
dividends, merger, reclassification or similar transactions affecting shares, the Board shall have the right to adjust the PSUs under this Plan, the number and price of shares and other matters, and the Board’s decision shall be final and
binding. If the Company issues any type of share or securities that can be converted into any type of share, the shares obtained by the Grantee due to Settlement of relevant PSUs will be diluted accordingly, that is, the proportion of such shares in
all issued shares of the Company will be reduced accordingly. 

  
 10 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	X.	 In the event that the Applicable Laws change or adjust, the Board may designate another entity’s
PSUs to replace the PSUs originally granted. The specific plan shall be decided by the Board and the Grantee shall accept it unconditionally. 

  

	XI.	 The Board has the right to terminate, revise or adjust this Plan in any event. 

 

	XII.	 The Board reserves the right to amend this Plan in accordance with Applicable Laws or as required for
the development of the Company, and the Grantee shall accept relevant future amendments. 

  

	XIII.	 Entire Agreement 

This Plan, the Grant Notification of PSU and the Notice Letter shall jointly constitute the entire agreement of the Grantees and the Company
with respect to this Plan and supersede all prior undertakings and agreements between the Company and the Grantees with respect to this Plan in their entirety. Nothing in this Plan, the Grant Notification of PSU and the Notice Letter (unless
expressly provided in such documents) shall be deemed to be intended to grant to any person other than the Grantees and the Company any rights or remedies. 
  

	XIV.	 Rights of Third Parties 

Except as otherwise expressly provided in this Plan, the Grant Notification of PSU and the Notice Letter, no party other than the parties
hereto shall be entitled to enforce this Plan, the Grant Notification of PSU and the Notice Letter under the Contracts (Rights of Third Parties) Ordinance (Chapter 623 of the Laws of Hong Kong) (the “Contracts (Rights of Third Parties)
Ordinance”). It does not affect the rights or relief that a third party exists or available outside of the Contracts (Rights of Third Parties) Ordinance. 
  

	XV.	 Governing Law 

This Plan, the Grant Notification of PSU and the Notice Letter shall be governed by and construed in accordance with Hong Kong laws. If any
provision of this this Plan, the Grant Notification of PSU and the Notice Letter is found to be invalid or unenforceable, then such provision shall be enforced to the fullest extent permitted by law, and the other provisions shall be valid and
enforceable. 
  

	XVI.	 Dispute Resolution 

Any dispute arising from this Plan, the Grant Notification of PSU and the Notice Letter or in relation to them shall be submitted to Hong Kong
International Arbitration Centre for arbitration which shall be conducted in accordance with the arbitration rules in effect at the time of applying for arbitration. The arbitration tribunal shall consist of 1 arbitrator. The arbitration place shall
be Hong Kong. The arbitration language shall be English. The arbitral award shall be final and binding upon the parties. 

  
 11 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

	XVII.	 Title 

The titles used in this Plan, the Grant Notification of PSU and the Notice Letter shall be for convenience only and shall not be deemed to be
part of the Document or affect the interpretation thereof. 
  

	XVIII.	 Notice 

Any notice required or permitted under this document shall be given electronically or in writing. If in writing, the notice shall be deemed
effectively given upon delivery to the 15th floor of China Ping An Finance Tower, No. 1333 Lujiazui Ring Road, Pudong New Area, Shanghai or as updated from time to time. 

  
 12 

  

 Confidential Treatment Requested by Lufax Holding Ltd Pursuant to 17 C.F.R. Section
200.83 
  

 Schedule A 

Performance Stock Unit Plan 

Calculation method of the Stock Price Coefficient and Performance Coefficient 

  
 13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00315-of-00352.parquet"}]]